Brainsway Ltd. Sponsored ADR
BWAY Healthcare Medical Devices
Brainsway Ltd. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $52.2 million, up 27.3% from fiscal 2024.
- Revenue
- +35.4%
- EPS
- +40.0%
- Free cash flow
- −51.7%
Quarter to June 2026, against a year earlier
Follow BWAY
Alert me
Brainsway Ltd. Sponsored ADR (BWAY) P/E ratio
As of 5 November 2026, Brainsway Ltd. Sponsored ADR (BWAY) trades at a P/E ratio of 21.2×. Over the past ten years it has ranged from 0.0× (June 2024) to 229× (September 2024); the current reading is higher than 69% of that period. That is below the Medical Devices industry median of 25.6× and below the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 23.8× | (57.14%) |
| FY2024 | 55.5× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 31.0× | 7.37% |
| Mar 2026 | 28.9× | 21.52% |
| Dec 2025 | 23.8× | (49.52%) |
| Sep 2025 | 47.1× | 0.28% |
| 31 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| SI Shoulder Innovations, Inc. compare | n/m |
| SENS Senseonics Holdings, Inc. compare | n/m |
| OFIX ORTHOFIX MEDICAL INC. compare | n/m |
| CERS Cerus Corporation compare | n/m |
| SSII SS Innovations International, Inc. compare | n/m |
| RCEL Avita Medical Inc. compare | n/m |
| NPCE NeuroPace, Inc. compare | n/m |
| MASS 908 Devices Inc. compare | n/m |
| BWAY Brainsway Ltd. Sponsored ADR | 21.2× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)